Metastatic patterns of breast cancer subtypes: what radiologists should know in the era of personalized cancer medicine

Clin Radiol. 2015 Jan;70(1):1-10. doi: 10.1016/j.crad.2014.08.015. Epub 2014 Oct 7. Chikarmane SA1, Tirumani SH2, Howard SA2, Jagannathan JP2, DiPiro PJ2 Abstract There is accumulating evidence that molecular phenotyping of breast cancer determines the timing, pattern, and outcome of metastatic disease. The most clinically relevant subtypes are hormonal-positive [oestrogen and progesterone receptor (ER/PR) positive], HER2 expressing,(…)